Effective and highly significant protection was demonstrated in mice immunized with TgMIC1-4-6 or TgMIC1-4, since 80% and 70% of the mice, respectively, survived to the acute phase of infection, which is compatible with the high protection reported to be conferred by immunization with the LAC+ fraction (21). This evidence concerns the gene LCT and infection.